Schentag J J
School of Pharmacy, State University of New York, Buffalo.
Clin Pharmacokinet. 1989;16 Suppl 1:25-31. doi: 10.2165/00003088-198900161-00005.
The concentrations achieved by a particular antibiotic in serum and tissues can be predicted from pharmacokinetic data. These predictions must be evaluated in the broader context of the patient's infection, particularly the MIC of the drug for the infecting organism. What is the relevant measurement - the serum concentration or the tissue to serum ratio? Are the serum and/or tissue concentrations achieved at the site of infection sufficiently in excess of the MIC to eradicate the organism? How long are these levels sustained? How often must the drug be given to keep the concentrations sufficiently in excess of the MIC to eradicate the organisms? This presentation will review these questions in the context of the major classes of antibiotics: the beta-lactams, aminoglycosides and quinolones.
通过药代动力学数据可以预测某种特定抗生素在血清和组织中所能达到的浓度。这些预测必须在患者感染的更广泛背景下进行评估,特别是该药物对感染病原体的最低抑菌浓度(MIC)。相关的测量指标是什么——血清浓度还是组织与血清的比率?在感染部位达到的血清和/或组织浓度是否足以超过最低抑菌浓度以根除病原体?这些水平能维持多久?必须多久给药一次才能使浓度充分超过最低抑菌浓度以根除病原体?本报告将在主要抗生素类别(β-内酰胺类、氨基糖苷类和喹诺酮类)的背景下审视这些问题。